Hanmi, Lundbeck Korea to reinforce local co-marketing of Ebixa for treatment of moderate to severe A

Published: 2009-12-02 06:56:00
Updated: 2009-12-02 06:56:00
Hanmi Pharm said on November 27 that it has signed an agreement with Lundbeck Korea with an aim to co-promote Ebixa (memantine 10mg), anti-dementia agent, in Korea for the next five years.

A November 26 signing ceremony were attended by Hanmi’s president Chang An-soo; his Lundbeck counterpart ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.